Dr. David George, M.D.
What this data tells you about Dr. George
Dr. David George is a hematology & oncology in Bastrop, TX, with 19 years in practice. Based on federal Medicare data, Dr. George performed 60,679 Medicare services across 2,461 unique beneficiaries.
Between the years covered by Open Payments, Dr. George received a total of $351 from 10 pharmaceutical and/or device companies across 12 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. George is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 18,360 | $0 | $5 |
| Iron sucrose injection (Venofer) | 15,500 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 10,400 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 6,000 | $0 | $5 |
| Dexamethasone injection (steroid) | 1,501 | $0 | $1 |
| Immune globulin infusion (Octagam) | 1,120 | $35 | $235 |
| Blood draw (venipuncture) | 862 | $8 | $20 |
| Complete blood count (CBC) with differential | 840 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 620 | $0 | $24 |
| Comprehensive metabolic blood panel | 561 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 460 | $1 | $114 |
| Office visit, established patient (30-39 min) | 435 | $91 | $368 |
| Injection, fluorouracil, 500 mg | 277 | $2 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 211 | $103 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 198 | $23 | $157 |
| Ferritin level test (iron stores) | 178 | $13 | $60 |
| Iron level test | 174 | $6 | $27 |
| Iron binding capacity test | 174 | $9 | $35 |
| Office visit, established patient (20-29 min) | 169 | $60 | $250 |
| Injection of additional new drug or substance into vein | 166 | $12 | $108 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 147 | $48 | $313 |
| Injection, zoledronic acid, 1 mg | 141 | $7 | $431 |
| Lactate dehydrogenase (enzyme) level | 138 | $6 | $31 |
| Microscopic examination for white blood cells with manual cell count | 138 | $4 | $22 |
| Complete blood count (CBC), automated | 137 | $6 | $34 |
| Immunoglobulin level test | 115 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 109 | $16 | $100 |
| Injection, magnesium sulfate, per 500 mg | 106 | $1 | $6 |
| Infusion, normal saline solution , 1000 cc | 102 | $2 | $19 |
| Hospital follow-up visit, high complexity | 100 | $91 | $357 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 90 | $56 | $211 |
| Measurement of immunoglobulin light chains | 88 | $17 | $60 |
| Red blood count, automated test | 84 | $4 | $23 |
| Drug injection, under skin or into muscle | 77 | $11 | $96 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 67 | $25 | $145 |
| Administration of chemotherapy into vein, each additional hour | 65 | $22 | $161 |
| Infusion into a vein for hydration, each additional hour | 63 | $10 | $75 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 52 | $20 | $128 |
| Injection, diphenhydramine hcl, up to 50 mg | 52 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 50 | $51 | $344 |
| Carcinoembryonic antigen (cea) protein level | 49 | $19 | $99 |
| Unclassified drugs | 48 | $1 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 42 | $26 | $256 |
| Office visit, established patient, complex (40-54 min) | 37 | $128 | $496 |
| Injection of drug or substance into vein | 34 | $29 | $247 |
| PSA test (prostate cancer screening) | 32 | $18 | $94 |
| Administration of additional new drug or substance into vein using push technique | 31 | $44 | $289 |
| New patient office visit (45-59 min) | 29 | $115 | $565 |
| Hospital follow-up visit, moderate complexity | 29 | $62 | $247 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 29 | $132 | $500 |
| Initial hospital admission, high complexity | 28 | $131 | $694 |
| Uric acid level test | 27 | $4 | $25 |
| Hospital follow-up visit, low complexity | 27 | $39 | $135 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 26 | $350 | $1,722 |
| New patient office visit, complex (60-74 min) | 20 | $158 | $709 |
| Protein measurement, serum | 18 | $11 | $99 |
| Immunologic analysis technique on serum | 16 | $29 | $108 |
| Immunologic analysis technique on serum (immunofixation) | 16 | $22 | $160 |
| Vitamin B-12 level test | 14 | $15 | $76 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
12.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. George is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and speaking/promotional industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. George experienced with iron infusion (feraheme)?
Does Dr. George receive payments from pharmaceutical companies?
How do Dr. George's costs compare to other hematology & oncologys in Bastrop?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology